Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis

BACKGROUND: Most current disease-modifying therapies approved for multiple sclerosis (MS) are immunomodulatory drugs that counteract the aberrant activity of the immune system. Hence, new pharmacological interventions that drive anti-inflammatory activity and neuroprotection would represent interest...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrillas-de la Cal, Alejandro, Torres-Sanchez, Sonia, Bravo, Lidia, Llorca-Torralba, Meritxell, Garcia-Partida, Jose Antonio, Arroba, Ana I., Berrocoso, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474779/
https://www.ncbi.nlm.nih.gov/pubmed/37658434
http://dx.doi.org/10.1186/s12974-023-02865-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474779/
https://www.ncbi.nlm.nih.gov/pubmed/37658434
http://dx.doi.org/10.1186/s12974-023-02865-z

Ejemplares similares